Afya Resultados de beneficios anteriores

Pasado controles de criterios 2/6

Afya ha aumentado sus ingresos a un ritmo medio anual de 22.3%, mientras que la industria Consumer Services ha visto aumentar sus ingresos growing a 18.2% anualmente. Los ingresos han crecido growing a un ritmo medio anual de 35.5%. Afya La rentabilidad de los fondos propios de la empresa es de 10.6% y sus márgenes netos son de 13%.

Información clave

21.6%

Tasa de crecimiento de los beneficios

14.3%

Tasa de crecimiento del BPA

Crecimiento de la industria Consumer Services	20.3%
Tasa de crecimiento de los ingresos	34.1%
Rentabilidad financiera	11.1%
Margen neto	13.4%
Próxima actualización de resultados	09 May 2024

Actualizaciones de resultados anteriores recientes

Recent updates

What Type Of Returns Would Afya's(NASDAQ:AFYA) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Dec 24

Afya BOD approves share buyback program

Dec 23

Afya reports Q3 results

Dec 03

Is Afya Limited's (NASDAQ:AFYA) 10% ROE Strong Compared To Its Industry?

Dec 03

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero Afya. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

NasdaqGS:AFYA Ingresos, gastos y beneficios (BRL Millions)
Fecha	Ingresos	Beneficios	Gastos G+A
31 Dec 23	2,876	386	1,002
30 Sep 23	2,730	355	928
30 Jun 23	2,587	337	882
31 Mar 23	2,473	356	840
31 Dec 22	2,329	374	797
30 Sep 22	2,243	352	762
30 Jun 22	2,117	329	730
31 Mar 22	1,891	245	658
31 Dec 21	1,719	223	623
30 Sep 21	1,566	235	559
30 Jun 21	1,421	257	485
31 Mar 21	1,323	300	440
31 Dec 20	1,201	292	403
30 Sep 20	1,077	285	356
30 Jun 20	974	257	323
31 Mar 20	878	212	292
31 Dec 19	751	154	239
30 Sep 19	636	128	184
30 Jun 19	522	106	132
31 Mar 19	417	110	87
31 Dec 18	334	86	70
31 Dec 17	216	45	45

Ingresos de calidad: AFYA tiene ganancias de alta calidad.

Margen de beneficios creciente: AFYALos actuales márgenes de beneficio netos de (13%) son inferiores a los del año pasado (15.7%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: AFYAEn los últimos 5 años, los beneficios de la empresa han crecido significativamente: 22.3% al año.

Acelerando crecimiento: AFYAEl crecimiento de los beneficios de la empresa en el último año (0.9%) está por debajo de su media de 5 años (22.3% al año).

Beneficios vs. Industria: AFYA El crecimiento de los beneficios en el último año (0.9%) no superó al del sector Consumer Services 8.2% .

Rentabilidad financiera

Alta ROE: El Retorno sobre el capital de AFYA (10.6%) se considera bajo.

Rentabilidad económica

Rendimiento del capital invertido

Descubre empresas con buenos resultados en el pasado

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Afya Resultados de beneficios anteriores

Pasado controles de criterios 2/6

Información clave

Actualizaciones de resultados anteriores recientes

Full year 2023 earnings: EPS misses analyst expectations

Afya Limited to Report Q4, 2023 Results on Mar 14, 2024

Third quarter 2023 earnings: Revenues and EPS in line with analyst expectations

Afya Limited to Report Q3, 2023 Results on Nov 13, 2023

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Afya Limited to Report Q2, 2023 Results on Aug 28, 2023

Recent updates

Afya (NASDAQ:AFYA) Seems To Use Debt Quite Sensibly

Afya Is Performing Well And Is A Buy

Full year 2023 earnings: EPS misses analyst expectations

Are Investors Undervaluing Afya Limited (NASDAQ:AFYA) By 39%?

Afya Limited Provides Earnings Guidance for the FY2024

Be Wary Of Afya (NASDAQ:AFYA) And Its Returns On Capital

Afya Limited (NASDAQ:AFYA) Not Lagging Market On Growth Or Pricing

Should You Think About Buying Afya Limited (NASDAQ:AFYA) Now?

Afya Limited to Report Q4, 2023 Results on Mar 14, 2024

These 4 Measures Indicate That Afya (NASDAQ:AFYA) Is Using Debt Reasonably Well

Consensus EPS estimates fall by 14%

Third quarter 2023 earnings: Revenues and EPS in line with analyst expectations

Consensus EPS estimates increase by 11%

Afya (NASDAQ:AFYA) May Have Issues Allocating Its Capital

Afya Limited to Report Q3, 2023 Results on Nov 13, 2023

What Does Afya Limited's (NASDAQ:AFYA) Share Price Indicate?

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Does Afya (NASDAQ:AFYA) Deserve A Spot On Your Watchlist?

Afya Limited to Report Q2, 2023 Results on Aug 28, 2023

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Afya Limited to Report Q1, 2023 Results on May 24, 2023

Afya Limited, Annual General Meeting, Jun 15, 2023

Investor sentiment improves as stock rises 19%

Full year 2022 earnings: EPS misses analyst expectations

Consensus EPS estimates increase by 12%

Afya Announces Changes to Its Board of Directors

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Less than half of directors are independent

Investor sentiment improved over the past week

Afya Limited to Report Q3, 2022 Results on Nov 21, 2022

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Afya GAAP EPS of R$1.12, revenue of R$598.16M; reaffirms FY22 guidance

Investor sentiment improved over the past week

White Brook Capital - AFYA Ltd: Cheap Stock, Good Business, Inherent Growth

Afya Limited to Report Q2, 2022 Results on Aug 22, 2022

Consensus forecasts updated

First quarter 2022 earnings: EPS exceeds analyst expectations

Investor sentiment deteriorated over the past week

Erste Wv GÜTersloh Gmbh signed a basic agreement to acquire additional 2.4% stake in Afya Limited (NasdaqGS:AFYA) from Nicolau Carvalho Esteves Rosângela de Oliveira Tavares Esteves and NRE Capital Ventures Ltd.

Less than half of directors are independent

Afya Limited Announces Changes to its Board of Directors

Afya Limited to Report Q1, 2022 Results on May 23, 2022

Afya Limited, Annual General Meeting, Apr 29, 2022

Afya: Margin And Organic Growth Struggles Remain Top Of Mind

Full year 2021 earnings: EPS misses analyst expectations

Investor sentiment improved over the past week

Consensus forecasts updated

Afya Limited to Report Q4, 2021 Results on Mar 31, 2022

Investor sentiment improved over the past week

Afya On A Grey Price Area

Consensus forecasts updated

Third quarter 2021 earnings: Revenues exceed analyst expectations

Afya: The Longer-Term Growth Story Remains Intact

Afya Limited Provides Earnings Guidance for the Second Half of 2021

Second quarter 2021 earnings released

Director Laura Carvalho has left the company

Bertelsmann SE& Co. KGaA completed the acquisition of 24.7% stake in Afya Limited (NasdaqGS:AFYA) from Bozano Educacional II Fundo de Investimento em Participações manged by Crescera Investimentos.

First quarter 2021 earnings released: EPS R$1.16 (vs R$1.09 in 1Q 2020)

Afya to acquire UNIGRANRIO for R$700M

Afya Limited announced that it has received BRL 822 million in funding from SoftBank Investment Advisers (UK) Limited

Full year 2020 earnings released: EPS R$3.15 (vs R$2.03 in FY 2019)

Afya Limited announced that it expects to receive BRL 822 million in funding from SoftBank Investment Advisers (UK) Limited

Full year 2020 earnings released: EPS R$3.15 (vs R$2.03 in FY 2019)

Afya Limited Provides Revenge Guidance for the Second Half of 2021

Here's Why I Think Afya (NASDAQ:AFYA) Is An Interesting Stock

New 90-day low: US$21.16

Is Afya Limited's (NASDAQ:AFYA) ROE Of 11% Impressive?

Is Afya (NASDAQ:AFYA) Using Too Much Debt?

A Look At The Intrinsic Value Of Afya Limited (NASDAQ:AFYA)

Desglose de ingresos y gastos
Beta